Abstract: A base body for cleaning or disinfecting a medical product includes a plurality of nozzles for releasing a cleaning medium. The base body is of a disc-based construction consisting of a plurality of plates arranged in succession. A cover plate can be connected to a supply line for a cleaning medium. A distributor plate is fluidically downstream from the cover plate including inlet lines. A nozzle plate is provided with the nozzles being fluidically connected to the inlet lines and open towards a face of the nozzle plate. An end cover plate is fluidically downstream from the cover, distributor and nozzle plate. The cover and nozzle plate each have a central through-clearance which is of a shape corresponding to the article's peripheral contour, where the nozzles are arranged lined up in succession along the inner periphery of the nozzle plate and being open towards the through-clearance.

Abstract: The invention concerns a method for machine cleaning and disinfecting objects, in particular medical and/or dental instruments and/or work equipment. According to the invention, the objects are ultrasonically cleaned in water in a working area of a cleaning and disinfection system, wherein after cleaning of the objects the water is removed from the working area up to a defined residual volume, The residual volume of water remaining in the working area is subsequently converted into water vapour by means of a heating element arranged in the working area (18). The objects (40) are thermally disinfected in the working area by means of the water vapour, wherein a vapour atmosphere in the working area s subsequently removed from the working area for drying the objects.

Abstract: An agent for producing medication for the treatment of depression and/or dementia disorders improves the effectivity of treatment of this illness compared to classical therapy through a combination of a substance which increases the dopamine concentration in the synaptic gap of the nerve cells of the brain and a local anaesthetic of the anilide group.

Abstract: With an agent for preparing a medication for treating the symptoms of Parkinson's disease, one obtains more effective treatment of the symptoms of said disease compared to classical treatment by a combination of effective substances comprising a substance increasing dopamine concentration in the synaptic cleft of the neurons of the brain along with a local anesthetic of the anilide group.